» Articles » PMID: 34131404

The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2021 Jun 16
PMID 34131404
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The transient receptor potential cation channel subfamily V member 1 (TRPV1) is a transmembrane protein that can be activated by various physical and chemical stimuli and is associated with pain transduction. In recent years, TRPV1 was discovered to play essential roles in cancer tumorigenesis and development, as TRPV1 expression levels are altered in numerous cancer cell types. Several investigations have discovered direct associations between TRPV1 and cancer cell proliferation, cell death, and metastasis. Furthermore, about two dozen TRPV1 agonists/antagonists are under clinical trial, as TRPV1 is a potential drug target for treating various diseases. Hence, more researchers are focusing on the effects of TRPV1 agonists or antagonists on cancer tumorigenesis and development. However, both agonists and antagonists may reveal anti-cancer effects, and the effect may function via or be independent of TRPV1. In this review, we provide an overview of the impact of TRPV1 on cancer cell proliferation, cell death, and metastasis, as well as on cancer therapy and the tumor microenvironment, and consider the implications of using TRPV1 agonists and antagonists for future research and potential therapeutic approaches.

Citing Articles

Pro-Apoptotic Effects of Anandamide in Human Gastric Cancer Cells Are Mediated by AKT and ERK Signaling Pathways.

Garcia-Hernandez V, Torres-Roman A, Ruiz-Garcia E, Santamaria A, Manzo-Merino J, Garcia-Lopez A Int J Mol Sci. 2025; 26(5).

PMID: 40076652 PMC: 11900069. DOI: 10.3390/ijms26052033.


Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies.

Melo E, Asevedo E, Duarte-Almeida J, Nurkolis F, Syahputra R, Park M Plants (Basel). 2025; 14(4).

PMID: 40006844 PMC: 11859785. DOI: 10.3390/plants14040585.


Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs.

Wan X, Ma J, Bai H, Hu X, Ma Y, Zhao M Biomolecules. 2025; 15(1).

PMID: 39858534 PMC: 11764138. DOI: 10.3390/biom15010140.


Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

Lu J, Jiang C, Drabick J, Joshi M, Perimbeti S Pharm Res. 2025; 42(1):25-47.

PMID: 39779619 PMC: 11785709. DOI: 10.1007/s11095-024-03809-9.


Targeting Perineural Invasion in Pancreatic Cancer.

Garajova I, Giovannetti E Cancers (Basel). 2025; 16(24.

PMID: 39766161 PMC: 11674953. DOI: 10.3390/cancers16244260.


References
1.
Fonseca B, Correia-da-Silva G, Teixeira N . Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem. 2018; 74(2):261-272. DOI: 10.1007/s13105-018-0611-7. View

2.
Li W, Lee Y, Kim J, Kang S, Kim S, Kim K . Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes. J Invest Dermatol. 2007; 127(10):2328-35. DOI: 10.1038/sj.jid.5700880. View

3.
Cavanaugh D, Chesler A, Jackson A, Sigal Y, Yamanaka H, Grant R . Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci. 2011; 31(13):5067-77. PMC: 3087977. DOI: 10.1523/JNEUROSCI.6451-10.2011. View

4.
Prevarskaya N, Ouadid-Ahidouch H, Skryma R, Shuba Y . Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1638):20130097. PMC: 3917351. DOI: 10.1098/rstb.2013.0097. View

5.
Farfariello V, Liberati S, Morelli M, Tomassoni D, Santoni M, Nabissi M . Resiniferatoxin induces death of bladder cancer cells associated with mitochondrial dysfunction and reduces tumor growth in a xenograft mouse model. Chem Biol Interact. 2014; 224:128-35. DOI: 10.1016/j.cbi.2014.10.020. View